Table 2.
Demographic and Clinical Characteristics of Patients With Positive Results for Coronavirus Disease 2019 After Full Vaccination
| Demographic and Clinical Characteristics | Patients, No. (n = 36)a |
|---|---|
| Age, median (range) | 47 (23 to >90) |
| Sex | |
| Male | 15 |
| Female | 21 |
| Symptomatic | |
| Yes | 19 |
| No | 17 |
| Comorbid conditions | |
| Obesity (BMI, >30b) | 11 |
| Hypertension | 11 |
| Cardiovascular disease | 7 |
| Diabetes | 2 |
| Asthma | 2 |
| Allergic rhinitis | 2 |
| History of cancer/ autoimmune disease/HIV/possible immunocompromise | 4 |
| Outpatient status (no admission) | 36 |
| Interval between 2nd vaccine dose and positive COVID-19 result, median (range), d | 31.5 (4–75) |
| Clinical assay Ct, median (range)c | 26.13 (14.35–37.88) |
| Data for 14 genomes with >90% coverage | |
| B.1.1.7 (collection in March 2021) | 9 |
| B.1.526 (collection in March 2021) | 2 |
| B.1.526.1 (collection in March 2021) | 1 |
| B.1.2 (collection in January 2021) | 1 |
| B.1.1 (collection in January 2021) | 1 |
Abbreviations: BMI, body mass index; COVID-19, coronavirus disease 2019; Ct, cycle threshold; HIV, human immunodeficiency virus.
aData represent no. of patients unless otherwise specified.
bBMI was calculated as weight in kilograms divided by height in meters squared.
cData available for only 23 samples.